Precision Public Health: Balancing Scientific Investment and Prevention

Precision public health assumes that individuals vary in their genetic makeup and that the response to their environment and their diseases differ as a result. Donna Arnett will summarize the rapid advancements in genomics over the past two decades and the impact of those advancements on disease prediction and treatment. She will argue that while precision public health has merit, public health researchers and providers must seek equipoise in balancing proven health promotion activities and scientific advancement to address the common diseases in the US. Please note that an ASL interpreter will be available at this event.